Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
China · Delayed Price · Currency is CNY 5.15
-0.05 (-0.96%)
Feb 13, 2026, 3:04 PM CST
SHE:002872 Revenue
Tiansheng Pharmaceutical Group had revenue of 116.62M CNY in the quarter ending September 30, 2025, a decrease of -3.57%. This brings the company's revenue in the last twelve months to 516.17M, down -10.28% year-over-year. In the year 2024, Tiansheng Pharmaceutical Group had annual revenue of 569.71M, down -1.66%.
Revenue (ttm)
516.17M
Revenue Growth
-10.28%
P/S Ratio
3.17
Revenue / Employee
405.79K
Employees
1,272
Market Cap
1.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 569.71M | -9.62M | -1.66% |
| Dec 31, 2023 | 579.33M | -27.66M | -4.56% |
| Jan 1, 2023 | 606.99M | -129.69M | -17.61% |
| Jan 1, 2022 | 736.69M | -466.06M | -38.75% |
| Dec 31, 2020 | 1.20B | -476.79M | -28.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang East Asia Pharmaceutical | 831.56M |
| Guiyang Xintian Pharmaceutical | 755.34M |
| Jilin Jian Yisheng Pharmaceutical | 639.10M |
| Hubei Goto Biopharm | 626.28M |
| Jiangsu Sihuan Bioengineering | 341.90M |
| Sailong Pharmaceutical Group | 244.84M |
| Shanghai Rightongene Biotechnology | 191.78M |
| Jiangsu CoWin Biotech | 167.17M |